Reducing the number of intravitreal injections to treat age-related macular degeneration (AMD) is a top priority in current ...

Detailed price information for Inmed Pharmaceuticals Inc (INM-Q) from The Globe and Mail including charting and trades.

The rapid growth in IVT injections has resulted from the introduction of novel drug therapies. In 2004, only 2 agents were specifically approved by the United States Food and Drug Administration ...

The updated label allows physicians to prescribe Izervay without a limitation on duration for patients with geographic ...

These intravitreal (in-the-eye) injections allow an ophthalmologist to place the medication directly into the vitreous cavity ...

The Food and Drug Administration (FDA) has approved Susvimo ® (ranibizumab injection) for the treatment of patients with diabetic macular edema (DME) who have previously responded to at least 2 ...

Intravitreal injection has been the established method for the effective delivery of drugs to the back of the eye and remains the standard of care among retinal specialists. Topical formulations ...

Lower rates of both progression of macular fibrosis and intravitreal aflibercept injections were found in those who used the resveratrol oral supplement. AMD is the leading cause of vision ...

Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions. Monitor your stock picks and compare them to top ...

Astellas Pharma Inc., a global life sciences company committed to turning innovative science into VALUE for patients, announced the submission of a New Drug Application (NDA) to Japan’s Ministry of ...